Cencora stock slips 1.30% for third straight daily loss

9 articles · Updated · MarketWatch · May 1

Shares closed at $304.00 as the S&P 500 rose 0.29% to 7,230.12 and the Dow Jones Industrial Average fell 0.31% to 49,499.27.
The stock finished 19.48% below its 52-week high of $377.54, reached on 25 November.
Against peers, Amazon gained 1.21%, while UnitedHealth fell 0.46% and CVS Health dropped 1.44% in a mixed session.

Analysts see a 25% upside for Cencora, so why do some valuation models suggest selling the stock now?

Can Cencora's big bet on specialty drugs overcome its rising debt and legal troubles from the opioid crisis?